Celso Albuquerque Reis

Title: The Innovative Mind of Celso Albuquerque Reis

Introduction

Celso Albuquerque Reis, based in Vila Nova de Gaia, Portugal, is a distinguished inventor recognized for his significant contributions to pharmaceutical sciences. With one patent to his name, his innovations focus on the modulation of polypeptide GalNAc-transferases, which play a crucial role in glycosylation processes.

Latest Patents

Reis holds a patent for "Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments." This groundbreaking invention unveils methods to manipulate the functions of GalNAc-transferases, introducing inhibitors that selectively target lectin domains without interfering with O-glycosylation processing.

Career Highlights

His career is marked by a pivotal focus on understanding the functionality of polypeptide GalNAc-transferases. The invention highlights that these enzymes have distinct lectin domains that recognize carbohydrates, enhancing their role in glycoengineering. By identifying and characterizing specific inhibitors, Reis has made a major advancement in drug formulation and development.

Collaborations

Throughout his career, Reis has collaborated with notable professionals in the field, including Henrik Clausen and Eric Bennett. Their collective expertise has undoubtedly enriched the research and development of pharmaceutical compositions that utilize the properties of GalNAc-transferases.

Conclusion

Celso Albuquerque Reis stands out as a visionary inventor in the realm of biotechnology and pharmaceutical solutions. His innovative approaches to the study of polypeptide GalNAc-transferases not only advance scientific understanding but also inspire future research in the development of therapeutic agents.